Our previous data on the diagnostic ability assessment of tumor markers in 246 patients with pancreatic cancer showed that CA19-9, Span-1, DUPAN2, and CEA levels were associated with diagnostic accuracy values of 74.3%, 69.6%, 57.3%, and 45.5%, respectively (data not published). The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.